CSI Market
Sign In | Register

Pediatrix Medical Group Inc (MD) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MD Annual Cash Flow →
Quarterly cash flow trends provide additional context on Pediatrix Medical Group Inc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income69.42
Depreciation & amortization11.90
Amortization of Other Assets0.15
Accretion Expense0.00
Restructuring & Impairment Charges13.40
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation8.40
Income (Loss) from Equity Method Investments1.39
Financial Instruments and Foreign Currency Transaction0.00
Payment Of Contingent Consideration Liability Operating-
Payment For Contingent Consideration Liability Operating Activities-
Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve-1.11
Income taxes0.00
Gain (Loss) on Investments-1.00
Increase (Decrease) in Accounts Receivable99.54
Increase (Decrease) in Accounts Payable and Accrued Liabilities-117.53
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-3.96
Other Working Capital-16.00
Other Noncash Income (Expense)1.33
Other net0.00
Payments for (Proceeds from) Other Operating Activities-70.24
Discontinued operations-1.33
Net Cash flow from Operating Activities-4.52
Investing Activities
Capital Expenditures-7.63
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Strategic Investments-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments8.14
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-7.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Sales of Business, Affiliate and Productive Assets0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.53
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-5.96
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-62.58
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-13.30
Line Of Credit Facility Payments For Amendment-
Payment Of Contingent Consideration Liability-
Excess Tax Benefit Related To Resolution Of Income Tax Matters-
Payments Of Contingent Consideration Liabilities-
Payment Of Contingent Consideration Liability Financing-
Repayments Of Long Term Capital Lease Obligation-0.48
Payments To Term Loan-6.25
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-75.88
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-12.15
Total Cash Flow-86.36
4 historic quarters locked

Sign in to unlock the full Pediatrix Medical Group Inc cash flow history.

Sign In Create Free Account

About Pediatrix Medical Group Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 4, 2026
  • Source: md-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-331513

Figures are derived from filed reports and may be restated. Historical data is subject to revision.